EP4252857

METHODS FOR REDUCING LIPOPROTEIN(A) LEVELS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9)

Court proceedings (1)

🇪🇺 UPCUPC_CFI_195/2025Düsseldorf Local Division
2026-06-08
Sanofi Biotechnologies SAS, Regeneron Pharmaceuticals Inc. v. Amgen Inc. a. o., Amgen GmbH +6
infringementEP42528571 document